Dyne Therapeutics Liabilities 2024

Dyne Therapeutics Aktienanalyse

What does Dyne Therapeutics do?

Dyne Therapeutics Inc. is a US biotechnology company specializing in the development of therapies for genetic muscle diseases (HMDs). The company was founded in 2018 and is headquartered in Waltham, Massachusetts. Dyne Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Dyne Therapeutics's Liabilities

Dyne Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Dyne Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Dyne Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Dyne Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Dyne Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Dyne Therapeutics stock

What is the level of liabilities of Dyne Therapeutics this year?

Dyne Therapeutics has a debt balance of 73.79 M USD this year.

What were the liabilities of Dyne Therapeutics compared to the previous year?

The liabilities of Dyne Therapeutics have increased by 36.65% increased compared to the previous year.

What are the consequences of high debt for investors of Dyne Therapeutics?

High liabilities can pose a risk for investors of Dyne Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Dyne Therapeutics?

Low liabilities mean that Dyne Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Dyne Therapeutics affect the company?

An increase in liabilities of Dyne Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Dyne Therapeutics affect the company?

A decrease in the liabilities of Dyne Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Dyne Therapeutics?

Some factors that can influence the liabilities of Dyne Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Dyne Therapeutics so important for investors?

The liabilities of Dyne Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Dyne Therapeutics take to modify the liabilities?

To change its liabilities, Dyne Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Dyne Therapeutics pay?

Over the past 12 months, Dyne Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dyne Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Dyne Therapeutics?

The current dividend yield of Dyne Therapeutics is .

When does Dyne Therapeutics pay dividends?

Dyne Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dyne Therapeutics?

Dyne Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Dyne Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dyne Therapeutics located?

Dyne Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dyne Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dyne Therapeutics from 8/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/20/2024.

When did Dyne Therapeutics pay the last dividend?

The last dividend was paid out on 8/20/2024.

What was the dividend of Dyne Therapeutics in the year 2023?

In the year 2023, Dyne Therapeutics distributed 0 USD as dividends.

In which currency does Dyne Therapeutics pay out the dividend?

The dividends of Dyne Therapeutics are distributed in USD.